EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The prostatic inflammation score and risk of biochemical recurrence following radical prostatectomy

Francesco Guzzi, Ugo Giovanni Falagario, Angelo Cormio, Antonella Ninivaggi, Marco Finati, Nicola d'Altilia, Antonio Fanelli, Ruggiero Antonio Fiorella, Gian Maria Busetto, Carlo Bettocchi, Daniele Castellani, Vincenza Conteduca und 3 weitere

World Journal of Urology · 2025

DOI: 10.1007/s00345-025-05977-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Urology, 2025. Verfasst von Francesco Guzzi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology and Renal Transplantation, Policlinico Foggia, University of Foggia, 71122, Foggia, Italy. Hauptthemen laut MEDLINE: Prostatectomy, Prostatic Neoplasms, Neoplasm Recurrence, Local, Prostatitis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università di Foggia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inflammatory processes are thought to contribute to the development and progression of prostate cancer (PCa). This study aimed to evaluate whether a novel Prostatic Inflammation Score (PIS), integrating Irani Grade (G) and Aggressiveness (A), could predict the risk of biochemical recurrence (BCR) following radical prostatectomy (RP).

Methods

Patients undergoing biopsy and RP between 2013 and 2023 were included. PIS was assessed on hematoxylin and eosin-stained biopsy cores: PIS 1 (G 0–1/A 0–1), PIS 2 (G 2–3/A 0–1), and PIS 3 (G 0–3/A 2–3). BCR, considered as two consecutive PSA readings of ≥ 0.2 ng/mL, was evaluated through multivariable Cox regression analysis.

Results

Among 679 patients (median follow-up: 36 months), 127 (18.7%) experienced BCR. Over a median follow-up of 36 months, 127 (18.7%) patients experienced BCR. BCR incidence at six years was highest in PIS 1 (30%) vs. PIS 2 (10%) and PIS 3 (9%) ( p = 0.002). Compared to PIS 1, hazard ratios (HR) for BCR were 0.44 (95% CI: 0.27–0.74) for PIS 2 and 0.37 (95% CI: 0.15–0.91) for PIS 3. IRANI G scores inversely correlated with BCR risk (HR = 0.44, 95% CI: 0.27–0.74), while IRANI A scores (2–3) showed a nonsignificant trend (HR = 0.41, 95% CI: 0.17–1.02, p = 0.054). Gleason grade and pT stage were significantly associated with BCR, while margin status and pN stage were not.

Conclusions

PIS 1 was found to be associated with BCR after RP. Should these findings be externally validated, PIS could represent a readily available inexpensive tool to predict BCR after RP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProstatectomyProstatic NeoplasmsNeoplasm Recurrence, LocalProstatitisHumansMaleMiddle AgedAgedProstate-Specific AntigenRisk AssessmentRetrospective StudiesNeoplasm Grading

Stichwörter der Autor:innen

Biochemical recurrenceProstate cancerProstate inflammationRadical prostatectomyRobotic surgery

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Department of Urology and Renal Transplantation, Policlinico Foggia, University of Foggia, 71122, Foggia, Italy.
  • Department of Urology and Renal Transplantation, Policlinico Foggia, University of Foggia, 71122, Foggia, Italy. ugofalagario@gmail.com.
  • Department of Molecular Medicine and Surgery, (Solna), Karolinska Institutet, Stockholm, Sweden. ugofalagario@gmail.com.
  • Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Department of Urology, Bonomo Teaching Hospital, 76123, Andria, Italy.
  • Urology Unit, Azienda Ospedaliero-Universitaria delle Macrhe Università Politecnica Delle Marche, Via Conca 71, 60126, Ancona, Italy.

Förderung

  • Università di Foggia

Zitieren

APA

Guzzi, F., Falagario, U. G., Cormio, A., Ninivaggi, A., Finati, M., d'Altilia, N., Fanelli, A., Fiorella, R. A., Busetto, G. M., Bettocchi, C., Castellani, D., Conteduca, V., Carrieri, G., Sanguedolce, F., & Cormio, L. (2025). The prostatic inflammation score and risk of biochemical recurrence following radical prostatectomy. World Journal of Urology. https://doi.org/10.1007/s00345-025-05977-8

Vancouver

Guzzi F, Falagario UG, Cormio A, Ninivaggi A, Finati M, d'Altilia N, et al. The prostatic inflammation score and risk of biochemical recurrence following radical prostatectomy. World Journal of Urology. 2025. doi:10.1007/s00345-025-05977-8

BibTeX
@article{Guzzi2025,
  author = {Guzzi, Francesco and Falagario, Ugo Giovanni and Cormio, Angelo and Ninivaggi, Antonella and Finati, Marco and d'Altilia, Nicola and Fanelli, Antonio and Fiorella, Ruggiero Antonio and Busetto, Gian Maria and Bettocchi, Carlo and Castellani, Daniele and Conteduca, Vincenza and Carrieri, Giuseppe and Sanguedolce, Francesca and Cormio, Luigi},
  title = {The prostatic inflammation score and risk of biochemical recurrence following radical prostatectomy},
  journal = {World Journal of Urology},
  year = {2025},
  doi = {10.1007/s00345-025-05977-8}
}
Kostenlos starten →